Journal of Endocrinology · 2000 · 37 citations · 44 references
Life SciencesEndocrinologyMolecular BiologyCell SignalingCellular ImmunologySignal TransductionCytokine BiologyCytokine Receptor SignalingCytokine SignalingGrowth Factor SignalingGrowth HormoneHormone SignalingGrowth Hormone Receptor SignalingGrowth Hormone ReceptorsHek293 Cell ExpressionJak-stat Signaling PathwayJanus Kinase-stat Signaling ActivationMitogen-activated Protein Kinase CascadesMitogen-activated Protein Kinase PathwaysReceptor Binding Specificity
The interaction of GH, interleukin (IL)-6 and glucocorticoids is likely to be important in regulating the GH-insulin-like growth factor (IGF)-I axis. The signalling cascades activated by GH and IL-6 appear to be very similar, as demonstrated by studies using overexpression of the receptor and other components of the Jak-Stat and mitogen-activated protein (MAP) kinase pathways. Here we show that the human embryonic kidney cell line 293 (HEK293) expresses GH and IL-6 receptors endogenously. To determine which specific pathways might be activated by the two cytokines, at physiological levels of all components, we studied GH and IL-6 mediated signal transduction both under basal conditions and in the presence of overexpressed receptors and Stat proteins. Our results suggest a receptor specificity of Jak2 for GH receptors, and Jak1 for IL-6 receptors. Stat activation in response to GH and IL-6 was determined by reporter gene induction. Both GH and IL-6 were able to induce the reporter gene containing the Stat5 responsive element (LHRE) but the IL-6 response appeared to be mediated mainly through Stat3 activation. In contrast, the reporter gene containing the Stat3 responsive element (SIE) was IL-6 specific. The levels of gene induction by GH and IL-6 were not altered by the co-stimulation with GH and IL-6, suggesting that there is little cross-talk at the Jak-Stat activation level between the two cytokines. Neither GH nor IL-6 activated the MAP-kinase responsive serum response element (SRE), unless GH receptors or gp130 were overexpressed. Transfection of Stat3 or Stat5 expression vectors enhanced the response to GH and IL-6. Stimulation with dexamethasone synergistically enhanced GH activation of the LHRE reporter gene but had no effect on the IL-6 activation of the same reporter or on the SIE reporter gene. Thus, our studies suggest that while each cytokine, GH and IL-6, may activate various members of the Jak-Stat pathway in overexpression studies, specific activation of Stat3 by IL-6 and of Jak2 and Stat5 by GH can be observed in HEK293 cells and that in this system the synergistic effect of dexamethasone appears specific for Stat5.
44
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Journal of the American Medical Association · 1909 · 7.9K citations · Full text
Proceedings of the National Academy of Sciences, USA
Current Biology · 1996 · 5.3K citations · Full text
Molecular and cellular endocrinology
Journal of Endocrinology · 1995 · 2K citations
Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Evan Parganas, Demin Wang, Dimitrios J. Stravopodis et al. · Cell · 1998 · 1.2K citations · Full text
Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase
Lawrence S. Argetsinger, George S. Campbell, Xianjie Yang et al. · Cell · 1993 · 994 citations · Full text